Makorsp. z o.o.

Primary education

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2021-08-27
Share capital
30,865,000.00 PLN
Registered address
ul. Hipolita Wawelberga 10, 01-188 Warszawa, Poland

Financials

Revenue history (in k)

From the notes

Current income tax (CIT due)$0

Filing timeliness

1 of 5 financial statements was filed late (for 2021, 88 days late).

  • 202506/07/2026
  • 202403/07/2025
  • 202327/06/2024
  • 202222/06/2023
  • 202111/10/2022
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Industry · Primary education23 / 179
Top 13%
Division · Education60 / 3,193
Top 1.9%
Top 1.9%
City · Warszawa6,833 / 56,958
Top 12%
Voivodeship · Mazowieckie9,733 / 77,118
Top 13%
Country · Poland37,174 / 297,873
Top 12%

Results vs industry

Revenue
This companyUSD 4.26mMedianUSD 1.10mAverageUSD 1.77m
Net profit
This companyUSD -99.76kMedianUSD 16.12kAverageUSD 139.52k
Operating costs
This companyUSD 4.27mMedianUSD 966.44kAverageUSD 1.54m
Assets
This companyUSD 3.38mMedianUSD 244.21kAverageUSD 1.08m

Authorized Representatives

Anna Bakuła Wasilewska – Management Board Member

Manner of representation

Each member of the management board represents the company independently.

Ownership

OwnerSharesShare valueStake
308,650$8,337,385.20100%

Beneficial owners

Person

Debt

No entries in the National Debtors Register (KRZ).

Real estate

TypeAmount
Land (incl. perpetual usufruct)
$57,581
Buildings and premises
$3M

Public aid

4 public aid cases recorded, with a total value of $14,984.

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,932
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$2,015
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$9,231

Competitors

FAQ

Last updated: 2026-10-07